| 1 | text | 2,344 |
| 2 | audit | 1,437 |
| 3 | trap | 417 |
| 4 | dot | 405 |
| 5 | sub | 401 |
| 6 | inclusive | 398 |
| 7 | atlas | 182 |
| 8 | prism | 182 |
| 9 | page | 169 |
| 10 | sup | 154 |
| 11 | /sub | 153 |
| 12 | excel | 143 |
| 13 | dream | 104 |
| 14 | /sup | 99 |
| 15 | eclipse | 70 |
| 16 | yeaple | 37 |
| 17 | sky | 32 |
| 18 | icpr | 31 |
| 19 | /i | 25 |
| 20 | macron | 25 |
| 21 | 677c | 24 |
| 22 | neutrino | 18 |
| 23 | 3435c | 15 |
| 24 | apft | 15 |
| 25 | hnr | 15 |
| 26 | ipdas | 15 |
| 27 | loss-frame | 14 |
| 28 | crrc | 13 |
| 29 | blown | 12 |
| 30 | luncheon | 11 |
| 31 | popart | 11 |
| 32 | e-e | 10 |
| 33 | hcahps | 10 |
| 34 | dvpi | 9 |
| 35 | /st | 8 |
| 36 | 140mmhg | 8 |
| 37 | 421c | 8 |
| 38 | /em | 7 |
| 39 | /formula | 7 |
| 40 | 34c | 7 |
| 41 | ab3 | 7 |
| 42 | epiq | 7 |
| 43 | lcdsg | 7 |
| 44 | -786t | 6 |
| 45 | 118a | 6 |
| 46 | 2677g | 6 |
| 47 | 70/100 | 6 |
| 48 | 90mmhg | 6 |
| 49 | c.*636a | 6 |
| 50 | c.933+3a | 6 |
| 51 | ivs14+1g | 6 |
| 52 | psunc | 6 |
| 53 | pygs | 6 |
| 54 | -1639g | 5 |
| 55 | -174g | 5 |
| 56 | 2.5mmol/l | 5 |
| 57 | 521t | 5 |
| 58 | =/ | 5 |
| 59 | c.118-307g | 5 |
| 60 | c.1a | 5 |
| 61 | c.421c | 5 |
| 62 | c.521t | 5 |
| 63 | cfef-ism | 5 |
| 64 | gwv | 5 |
| 65 | heart-age | 5 |
| 66 | ipcrg | 5 |
| 67 | mir-499a | 5 |
| 68 | ungrammatical | 5 |
| 69 | β-score | 5 |
| 70 | -629c | 4 |
| 71 | /=80mmhg | 4 |
| 72 | 10kda | 4 |
| 73 | 1192g | 4 |
| 74 | 1451c | 4 |
| 75 | 1725g | 4 |
| 76 | 2011-19228-002 | 4 |
| 77 | 6986a | 4 |
| 78 | 744c | 4 |
| 79 | 894g | 4 |
| 80 | 957g | 4 |
| 81 | belgians | 4 |
| 82 | bmimnsa | 4 |
| 83 | c.463c | 4 |
| 84 | cfoa | 4 |
| 85 | e/e' | 4 |
| 86 | headline | 4 |
| 87 | inpact | 4 |
| 88 | m.1555a | 4 |
| 89 | m.3243a | 4 |
| 90 | maude | 4 |
| 91 | max-i | 4 |
| 92 | non-education | 4 |
| 93 | point-of-decision | 4 |
| 94 | qbtest | 4 |
| 95 | sfsc | 4 |
| 96 | sql | 4 |
| 97 | trans-2-nonenal | 4 |
| 98 | βoh | 4 |
| 99 | γ-cd | 4 |
| 100 | +5650a | 3 |
| 101 | +5714g | 3 |
| 102 | -1984a | 3 |
| 103 | -204a | 3 |
| 104 | -572g | 3 |
| 105 | -604t | 3 |
| 106 | -900g | 3 |
| 107 | /inf | 3 |
| 108 | 0.07-0.59 | 3 |
| 109 | 1/1,000 | 3 |
| 110 | 1166a | 3 |
| 111 | 142t | 3 |
| 112 | 1976c | 3 |
| 113 | 2168a | 3 |
| 114 | 2846a | 3 |
| 115 | 3□ | 3 |
| 116 | 40-ms | 3 |
| 117 | 40kg | 3 |
| 118 | 6.0mg/dl | 3 |
| 119 | 681g | 3 |
| 120 | 936c | 3 |
| 121 | acceptance/refusal | 3 |
| 122 | acknowledgments | 3 |
| 123 | adhd-rs-i | 3 |
| 124 | amrit | 3 |
| 125 | arg136 | 3 |
| 126 | baff-871c | 3 |
| 127 | br/ | 3 |
| 128 | c.*1794c | 3 |
| 129 | c.*22c | 3 |
| 130 | c.*231a | 3 |
| 131 | c.*77c | 3 |
| 132 | c.118-308c | 3 |
| 133 | c.241c | 3 |
| 134 | c.266c | 3 |
| 135 | c.388a | 3 |
| 136 | c.516g | 3 |
| 137 | c.556-2a | 3 |
| 138 | ccmm | 3 |
| 139 | ce/tio2-20sio2-3.5al2o3 | 3 |
| 140 | countermarketing | 3 |
| 141 | dsofa | 3 |
| 142 | electrochemiluminescence-molecular | 3 |
| 143 | hc3.2 | 3 |
| 144 | hpmk | 3 |
| 145 | hspa1b-179c | 3 |
| 146 | iavc | 3 |
| 147 | ibfat | 3 |
| 148 | ivs5-1g | 3 |
| 149 | lif-csf | 3 |
| 150 | mir-149c | 3 |
| 151 | mrvenc | 3 |
| 152 | octn1-917c | 3 |
| 153 | or/hr | 3 |
| 154 | pager | 3 |
| 155 | pidd5 | 3 |
| 156 | postcon-60s | 3 |
| 157 | rs35599367c | 3 |
| 158 | serca-2 | 3 |
| 159 | sidebar | 3 |
| 160 | +378g | 2 |
| 161 | +405g | 2 |
| 162 | +45t | 2 |
| 163 | -1306c | 2 |
| 164 | -2-methylpropyl | 2 |
| 165 | -250g | 2 |
| 166 | -287g | 2 |
| 167 | -3186c | 2 |
| 168 | -458g | 2 |
| 169 | 0.01/control | 2 |
| 170 | 0.25-1.15 | 2 |
| 171 | 1025t | 2 |
| 172 | 1236c | 2 |
| 173 | 1267a | 2 |
| 174 | 1298a | 2 |
| 175 | 12g/d | 2 |
| 176 | 1459c | 2 |
| 177 | 175a | 2 |
| 178 | 1896c | 2 |
| 179 | 200/microliter | 2 |
| 180 | 2004-15935-005 | 2 |
| 181 | 2166c | 2 |
| 182 | 2382c | 2 |
| 183 | 2430t | 2 |
| 184 | 263c | 2 |
| 185 | 3.3-4.7 | 2 |
| 186 | 341t | 2 |
| 187 | 3ng/ml | 2 |
| 188 | 406a | 2 |
| 189 | 472g | 2 |
| 190 | 5331g | 2 |
| 191 | 590g | 2 |
| 192 | 5α-reductase-1 | 2 |
| 193 | 60yrs | 2 |
| 194 | 61a | 2 |
| 195 | =130/ | 2 |
| 196 | acr-pedi30 | 2 |
| 197 | amthi | 2 |
| 198 | anger-framed | 2 |
| 199 | anilinopirymidynes | 2 |
| 200 | ar-c69931mx | 2 |
| 201 | benefit-only | 2 |
| 202 | c.*1025t | 2 |
| 203 | c.*2041t | 2 |
| 204 | c.-64t | 2 |
| 205 | c.1003c | 2 |
| 206 | c.1081c | 2 |
| 207 | c.1150c | 2 |
| 208 | c.1158c | 2 |
| 209 | c.118c | 2 |
| 210 | c.1477c | 2 |
| 211 | c.1799t | 2 |
| 212 | c.181t | 2 |
| 213 | c.1844c | 2 |
| 214 | c.2633+1g | 2 |
| 215 | c.26c | 2 |
| 216 | c.3076c | 2 |
| 217 | c.31g | 2 |
| 218 | c.397t | 2 |
| 219 | c.445c | 2 |
| 220 | c.618g | 2 |
| 221 | c.726+54c | 2 |
| 222 | c.76c | 2 |
| 223 | c.79g | 2 |
| 224 | c.866g | 2 |
| 225 | c.935g | 2 |
| 226 | cat-262c | 2 |
| 227 | catc.66+78c | 2 |
| 228 | computer-triggered | 2 |
| 229 | cqrm | 2 |
| 230 | ethylene-bis-dytiokarbamates | 2 |
| 231 | ex4-76c | 2 |
| 232 | false-alarm-prone | 2 |
| 233 | g.-158c | 2 |
| 234 | g.11187g | 2 |
| 235 | gapp | 2 |
| 236 | gigadb | 2 |
| 237 | iief/domain | 2 |
| 238 | infrared-dried | 2 |
| 239 | ivs16-2a | 2 |
| 240 | ivs7-2a | 2 |
| 241 | ivsh-9c | 2 |
| 242 | lipogram | 2 |
| 243 | mcph1-2550-c | 2 |
| 244 | men/ | 2 |
| 245 | metal-jacketed | 2 |
| 246 | nct01204502 | 2 |
| 247 | nct01586780 | 2 |
| 248 | o34 | 2 |
| 249 | oatp1c1-intron3c | 2 |
| 250 | pathology-correlate | 2 |
| 251 | placebo-tailored | 2 |
| 252 | positively-framed | 2 |
| 253 | problems» | 2 |
| 254 | prompt-type | 2 |
| 255 | ramadan-focused | 2 |
| 256 | risk-only | 2 |
| 257 | rrm1-37c | 2 |
| 258 | rs13702t | 2 |
| 259 | rs2448490g | 2 |
| 260 | rs3741379g | 2 |
| 261 | rs3814058c | 2 |
| 262 | rs931127a | 2 |
| 263 | rules-based | 2 |
| 264 | sphero-cylindrical | 2 |
| 265 | tctt | 2 |
| 266 | tnf-308g | 2 |
| 267 | topbp1-3257-a | 2 |
| 268 | tus-gfp | 2 |
| 269 | www.crash.lshtm.ac.uk | 2 |
| 270 | ≤/ | 2 |
| 271 | 'conflicting | 1 |
| 272 | 'steam | 1 |
| 273 | +3003t | 1 |
| 274 | +69c | 1 |
| 275 | -1.1-0.5 | 1 |
| 276 | -1131t | 1 |
| 277 | -429t | 1 |
| 278 | -50g | 1 |
| 279 | -514c | 1 |
| 280 | -524t | 1 |
| 281 | -842g | 1 |
| 282 | -terphenyl | 1 |
| 283 | .0001-and | 1 |
| 284 | /=-2 | 1 |
| 285 | /strong | 1 |
| 286 | 0-0.40 | 1 |
| 287 | 0.05.twenty-five | 1 |
| 288 | 0.10g/d | 1 |
| 289 | 0.20-1.02 | 1 |
| 290 | 0.27microm | 1 |
| 291 | 0.4mom | 1 |
| 292 | 1.05. | 1 |
| 293 | 1.45-5.61 | 1 |
| 294 | 10.0/12.0 | 1 |
| 295 | 11193t | 1 |
| 296 | 1236g | 1 |
| 297 | 127,458 | 1 |
| 298 | 1298c | 1 |
| 299 | 15:325-328 | 1 |
| 300 | 18281g | 1 |
| 301 | 191c | 1 |
| 302 | 1compared | 1 |
| 303 | 2008-07317-008 | 1 |
| 304 | 2010-18776-001 | 1 |
| 305 | 2011-19419-001 | 1 |
| 306 | 2015-15269-001 | 1 |
| 307 | 211ag | 1 |
| 308 | 22-32.5 | 1 |
| 309 | 25-topic | 1 |
| 310 | 2678g | 1 |
| 311 | 277a | 1 |
| 312 | 29,385 | 1 |
| 313 | 2col2 | 1 |
| 314 | 3050c | 1 |
| 315 | 31:1249-1263 | 1 |
| 316 | 3244-2a | 1 |
| 317 | 335t | 1 |
| 318 | 347,500 | 1 |
| 319 | 34:1885-1903 | 1 |
| 320 | 34:588-599 | 1 |
| 321 | 388a | 1 |
| 322 | 3953c | 1 |
| 323 | 3mg/mmol | 1 |
| 324 | 4-cqa | 1 |
| 325 | 4000pg/ml | 1 |
| 326 | 420-780 | 1 |
| 327 | 465,754 | 1 |
| 328 | 48867a | 1 |
| 329 | 491.4 | 1 |
| 330 | 4□ | 1 |
| 331 | 5.0/7.0 | 1 |
| 332 | 5/100mm | 1 |
| 333 | 500cells/μl | 1 |
| 334 | 531-2a | 1 |
| 335 | 56,451 | 1 |
| 336 | 66a | 1 |
| 337 | 857g | 1 |
| 338 | 8622c | 1 |
| 339 | =1750g | 1 |
| 340 | == | 1 |
| 341 | abstinence-promoting | 1 |
| 342 | acefhigh | 1 |
| 343 | acetylcholinestrease | 1 |
| 344 | acknowledgements | 1 |
| 345 | adenine/guanine | 1 |
| 346 | adpβs | 1 |
| 347 | akt1-snp4g | 1 |
| 348 | alme | 1 |
| 349 | amorphicity | 1 |
| 350 | anti-insecticide | 1 |
| 351 | apology/responsibility | 1 |
| 352 | astlevels | 1 |
| 353 | atropine-premedication | 1 |
| 354 | atropinics | 1 |
| 355 | bakhtiari | 1 |
| 356 | barley-β-d-glucan | 1 |
| 357 | behar | 1 |
| 358 | behavior-matched | 1 |
| 359 | brain/behaviour | 1 |
| 360 | c.*+118a | 1 |
| 361 | c.*1961c | 1 |
| 362 | c.-1088c | 1 |
| 363 | c.-460 | 1 |
| 364 | c.1133a | 1 |
| 365 | c.1171g | 1 |
| 366 | c.1195c | 1 |
| 367 | c.1222c | 1 |
| 368 | c.1252t | 1 |
| 369 | c.1305c | 1 |
| 370 | c.1330g | 1 |
| 371 | c.1393-1g | 1 |
| 372 | c.1400c | 1 |
| 373 | c.1456c | 1 |
| 374 | c.1720c | 1 |
| 375 | c.175g | 1 |
| 376 | c.1863+94a | 1 |
| 377 | c.1915g | 1 |
| 378 | c.224g | 1 |
| 379 | c.234+1g | 1 |
| 380 | c.2430t | 1 |
| 381 | c.259t | 1 |
| 382 | c.2929c | 1 |
| 383 | c.301c | 1 |
| 384 | c.3038a | 1 |
| 385 | c.327g | 1 |
| 386 | c.345-2a | 1 |
| 387 | c.377a | 1 |
| 388 | c.378c | 1 |
| 389 | c.37a | 1 |
| 390 | c.388c | 1 |
| 391 | c.396c | 1 |
| 392 | c.4005-1g | 1 |
| 393 | c.406t | 1 |
| 394 | c.4213c | 1 |
| 395 | c.422a | 1 |
| 396 | c.4486t | 1 |
| 397 | c.4519c | 1 |
| 398 | c.459+1g | 1 |
| 399 | c.482g | 1 |
| 400 | c.4956g | 1 |
| 401 | c.4975c | 1 |
| 402 | c.4987-3c | 1 |
| 403 | c.4g | 1 |
| 404 | c.5002t | 1 |
| 405 | c.506g | 1 |
| 406 | c.506t | 1 |
| 407 | c.5152+5g | 1 |
| 408 | c.5219+1g | 1 |
| 409 | c.539c | 1 |
| 410 | c.578t | 1 |
| 411 | c.592c | 1 |
| 412 | c.597c | 1 |
| 413 | c.629c | 1 |
| 414 | c.631g | 1 |
| 415 | c.639+5g | 1 |
| 416 | c.653c | 1 |
| 417 | c.674c | 1 |
| 418 | c.6884g | 1 |
| 419 | c.692c | 1 |
| 420 | c.712g | 1 |
| 421 | c.722a | 1 |
| 422 | c.729+18c | 1 |
| 423 | c.7480c | 1 |
| 424 | c.74c | 1 |
| 425 | c.784-1g | 1 |
| 426 | c.785a | 1 |
| 427 | c.78g | 1 |
| 428 | c.797g | 1 |
| 429 | c.8175g | 1 |
| 430 | c.837-1g | 1 |
| 431 | c.844c | 1 |
| 432 | c.8754+3g | 1 |
| 433 | c.886-3c | 1 |
| 434 | c.90c | 1 |
| 435 | c.913+1g | 1 |
| 436 | c.92+1g | 1 |
| 437 | c.92+6t | 1 |
| 438 | c.926a | 1 |
| 439 | c.93-21g | 1 |
| 440 | c.9610c | 1 |
| 441 | c.97c | 1 |
| 442 | campesterol≈β-sitosterol≥stigmasterol | 1 |
| 443 | chr17:40693129a | 1 |
| 444 | cin-lesions | 1 |
| 445 | colleague-to-colleague | 1 |
| 446 | consensus-recommended | 1 |
| 447 | cornea/sclera | 1 |
| 448 | ctri/2011/10/002094 | 1 |
| 449 | cv/ccc | 1 |
| 450 | cyp2d6≫cyp3a4 | 1 |
| 451 | decurarisation | 1 |
| 452 | des-ciclesonide | 1 |
| 453 | disadvantageously | 1 |
| 454 | doi:10.1002/sim.3113 | 1 |
| 455 | dot-joining | 1 |
| 456 | dqtend | 1 |
| 457 | e713k | 1 |
| 458 | ebmeds | 1 |
| 459 | ecg/cg | 1 |
| 460 | eds. | 1 |
| 461 | eeg/eps | 1 |
| 462 | egfr-216g | 1 |
| 463 | electroco- | 1 |
| 464 | encymatic | 1 |
| 465 | endopolygalacturonase | 1 |
| 466 | ex15+572t | 1 |
| 467 | ex3-104c | 1 |
| 468 | ex5+123c | 1 |
| 469 | expert/professional | 1 |
| 470 | fluorescence-dequenching | 1 |
| 471 | g.13863c | 1 |
| 472 | g.2603t | 1 |
| 473 | g.4338t | 1 |
| 474 | g.5082c | 1 |
| 475 | g.6986a | 1 |
| 476 | g.7920c | 1 |
| 477 | gem05 | 1 |
| 478 | gucca | 1 |
| 479 | h2silibr | 1 |
| 480 | horna | 1 |
| 481 | hr98pp | 1 |
| 482 | hspa1b1267a | 1 |
| 483 | hygiene/barrier | 1 |
| 484 | information-specific | 1 |
| 485 | intein-mediated | 1 |
| 486 | iqcode-sf | 1 |
| 487 | iron-blood | 1 |
| 488 | isorhaponticin | 1 |
| 489 | ivs1-181c | 1 |
| 490 | ivs10+1g | 1 |
| 491 | ivs3-1g | 1 |
| 492 | ivs4+1g | 1 |
| 493 | ivs4+919g | 1 |
| 494 | ivs5+3a | 1 |
| 495 | ivs6-1g | 1 |
| 496 | ivs7+1g | 1 |
| 497 | jeeves | 1 |
| 498 | kg® | 1 |
| 499 | ldlr+patients | 1 |
| 500 | lecithotrophy | 1 |
| 501 | length-itpka | 1 |
| 502 | m.14484t | 1 |
| 503 | m.3460g | 1 |
| 504 | m.8344a | 1 |
| 505 | m.8344g | 1 |
| 506 | m11778g | 1 |
| 507 | m6/m6'-o-sulphate | 1 |
| 508 | mania≥hypomania≥mixed-states≥psychosis | 1 |
| 509 | median+ficolin-2 | 1 |
| 510 | methlamino | 1 |
| 511 | mmol/mmoverline | 1 |
| 512 | ms/dd-ms | 1 |
| 513 | mtr-2756a | 1 |
| 514 | much/a | 1 |
| 515 | nampt-948g | 1 |
| 516 | nct00152204 | 1 |
| 517 | nct01691053 | 1 |
| 518 | neutrally-framed | 1 |
| 519 | nimh-genetics | 1 |
| 520 | non-deliverable | 1 |
| 521 | not-remembered | 1 |
| 522 | nrmp | 1 |
| 523 | oldenburger | 1 |
| 524 | or=-1.95 | 1 |
| 525 | or=-2.0 | 1 |
| 526 | or=30-day | 1 |
| 527 | ostradiol | 1 |
| 528 | partner/family | 1 |
| 529 | password=cunningham | 1 |
| 530 | pc25 | 1 |
| 531 | placebo-condition | 1 |
| 532 | pre-vignette | 1 |
| 533 | prime-sponsored | 1 |
| 534 | print-format | 1 |
| 535 | protein-hsp104 | 1 |
| 536 | psvmean | 1 |
| 537 | razavi | 1 |
| 538 | rentrop-grade | 1 |
| 539 | reposting | 1 |
| 540 | rs5883-c | 1 |
| 541 | rs9930761-t | 1 |
| 542 | rv5/rv6 | 1 |
| 543 | self-uncertain | 1 |
| 544 | several-folds | 1 |
| 545 | slickgone | 1 |
| 546 | sms/text | 1 |
| 547 | solvent-water | 1 |
| 548 | statpac | 1 |
| 549 | studies.key | 1 |
| 550 | symol | 1 |
| 551 | system-defined | 1 |
| 552 | testes-ni | 1 |
| 553 | text-articles | 1 |
| 554 | text/graphical | 1 |
| 555 | text/voice | 1 |
| 556 | the+3a | 1 |
| 557 | threat-framed | 1 |
| 558 | tm1camb | 1 |
| 559 | tm1fcr | 1 |
| 560 | town:2004 | 1 |
| 561 | tritri | 1 |
| 562 | tuh | 1 |
| 563 | unpleasent | 1 |
| 564 | unspoken | 1 |
| 565 | use-the | 1 |
| 566 | v158m | 1 |
| 567 | value-framed | 1 |
| 568 | waterhammer | 1 |
| 569 | weaker-risk | 1 |
| 570 | worse/low | 1 |
| 571 | www.cochranelibrary | 1 |
| 572 | znbr | 1 |
| 573 | γ-glutamil-transpeptidase | 1 |
| 1 | 'conflicting | 1 |
| 2 | 'steam | 1 |
| 3 | +3003t | 1 |
| 4 | +378g | 2 |
| 5 | +405g | 2 |
| 6 | +45t | 2 |
| 7 | +5650a | 3 |
| 8 | +5714g | 3 |
| 9 | +69c | 1 |
| 10 | -1.1-0.5 | 1 |
| 11 | -1131t | 1 |
| 12 | -1306c | 2 |
| 13 | -1639g | 5 |
| 14 | -174g | 5 |
| 15 | -1984a | 3 |
| 16 | -2-methylpropyl | 2 |
| 17 | -204a | 3 |
| 18 | -250g | 2 |
| 19 | -287g | 2 |
| 20 | -3186c | 2 |
| 21 | -429t | 1 |
| 22 | -458g | 2 |
| 23 | -50g | 1 |
| 24 | -514c | 1 |
| 25 | -524t | 1 |
| 26 | -572g | 3 |
| 27 | -604t | 3 |
| 28 | -629c | 4 |
| 29 | -786t | 6 |
| 30 | -842g | 1 |
| 31 | -900g | 3 |
| 32 | -terphenyl | 1 |
| 33 | .0001-and | 1 |
| 34 | /=-2 | 1 |
| 35 | /=80mmhg | 4 |
| 36 | /em | 7 |
| 37 | /formula | 7 |
| 38 | /i | 25 |
| 39 | /inf | 3 |
| 40 | /st | 8 |
| 41 | /strong | 1 |
| 42 | /sub | 153 |
| 43 | /sup | 99 |
| 44 | 0-0.40 | 1 |
| 45 | 0.01/control | 2 |
| 46 | 0.05.twenty-five | 1 |
| 47 | 0.07-0.59 | 3 |
| 48 | 0.10g/d | 1 |
| 49 | 0.20-1.02 | 1 |
| 50 | 0.25-1.15 | 2 |
| 51 | 0.27microm | 1 |
| 52 | 0.4mom | 1 |
| 53 | 1.05. | 1 |
| 54 | 1.45-5.61 | 1 |
| 55 | 1/1,000 | 3 |
| 56 | 10.0/12.0 | 1 |
| 57 | 1025t | 2 |
| 58 | 10kda | 4 |
| 59 | 11193t | 1 |
| 60 | 1166a | 3 |
| 61 | 118a | 6 |
| 62 | 1192g | 4 |
| 63 | 1236c | 2 |
| 64 | 1236g | 1 |
| 65 | 1267a | 2 |
| 66 | 127,458 | 1 |
| 67 | 1298a | 2 |
| 68 | 1298c | 1 |
| 69 | 12g/d | 2 |
| 70 | 140mmhg | 8 |
| 71 | 142t | 3 |
| 72 | 1451c | 4 |
| 73 | 1459c | 2 |
| 74 | 15:325-328 | 1 |
| 75 | 1725g | 4 |
| 76 | 175a | 2 |
| 77 | 18281g | 1 |
| 78 | 1896c | 2 |
| 79 | 191c | 1 |
| 80 | 1976c | 3 |
| 81 | 1compared | 1 |
| 82 | 2.5mmol/l | 5 |
| 83 | 200/microliter | 2 |
| 84 | 2004-15935-005 | 2 |
| 85 | 2008-07317-008 | 1 |
| 86 | 2010-18776-001 | 1 |
| 87 | 2011-19228-002 | 4 |
| 88 | 2011-19419-001 | 1 |
| 89 | 2015-15269-001 | 1 |
| 90 | 211ag | 1 |
| 91 | 2166c | 2 |
| 92 | 2168a | 3 |
| 93 | 22-32.5 | 1 |
| 94 | 2382c | 2 |
| 95 | 2430t | 2 |
| 96 | 25-topic | 1 |
| 97 | 263c | 2 |
| 98 | 2677g | 6 |
| 99 | 2678g | 1 |
| 100 | 277a | 1 |
| 101 | 2846a | 3 |
| 102 | 29,385 | 1 |
| 103 | 2col2 | 1 |
| 104 | 3.3-4.7 | 2 |
| 105 | 3050c | 1 |
| 106 | 31:1249-1263 | 1 |
| 107 | 3244-2a | 1 |
| 108 | 335t | 1 |
| 109 | 341t | 2 |
| 110 | 3435c | 15 |
| 111 | 347,500 | 1 |
| 112 | 34:1885-1903 | 1 |
| 113 | 34:588-599 | 1 |
| 114 | 34c | 7 |
| 115 | 388a | 1 |
| 116 | 3953c | 1 |
| 117 | 3mg/mmol | 1 |
| 118 | 3ng/ml | 2 |
| 119 | 3□ | 3 |
| 120 | 4-cqa | 1 |
| 121 | 40-ms | 3 |
| 122 | 4000pg/ml | 1 |
| 123 | 406a | 2 |
| 124 | 40kg | 3 |
| 125 | 420-780 | 1 |
| 126 | 421c | 8 |
| 127 | 465,754 | 1 |
| 128 | 472g | 2 |
| 129 | 48867a | 1 |
| 130 | 491.4 | 1 |
| 131 | 4□ | 1 |
| 132 | 5.0/7.0 | 1 |
| 133 | 5/100mm | 1 |
| 134 | 500cells/μl | 1 |
| 135 | 521t | 5 |
| 136 | 531-2a | 1 |
| 137 | 5331g | 2 |
| 138 | 56,451 | 1 |
| 139 | 590g | 2 |
| 140 | 5α-reductase-1 | 2 |
| 141 | 6.0mg/dl | 3 |
| 142 | 60yrs | 2 |
| 143 | 61a | 2 |
| 144 | 66a | 1 |
| 145 | 677c | 24 |
| 146 | 681g | 3 |
| 147 | 6986a | 4 |
| 148 | 70/100 | 6 |
| 149 | 744c | 4 |
| 150 | 857g | 1 |
| 151 | 8622c | 1 |
| 152 | 894g | 4 |
| 153 | 90mmhg | 6 |
| 154 | 936c | 3 |
| 155 | 957g | 4 |
| 156 | =/ | 5 |
| 157 | =130/ | 2 |
| 158 | =1750g | 1 |
| 159 | == | 1 |
| 160 | ab3 | 7 |
| 161 | abstinence-promoting | 1 |
| 162 | acceptance/refusal | 3 |
| 163 | acefhigh | 1 |
| 164 | acetylcholinestrease | 1 |
| 165 | acknowledgements | 1 |
| 166 | acknowledgments | 3 |
| 167 | acr-pedi30 | 2 |
| 168 | adenine/guanine | 1 |
| 169 | adhd-rs-i | 3 |
| 170 | adpβs | 1 |
| 171 | akt1-snp4g | 1 |
| 172 | alme | 1 |
| 173 | amorphicity | 1 |
| 174 | amrit | 3 |
| 175 | amthi | 2 |
| 176 | anger-framed | 2 |
| 177 | anilinopirymidynes | 2 |
| 178 | anti-insecticide | 1 |
| 179 | apft | 15 |
| 180 | apology/responsibility | 1 |
| 181 | ar-c69931mx | 2 |
| 182 | arg136 | 3 |
| 183 | astlevels | 1 |
| 184 | atlas | 182 |
| 185 | atropine-premedication | 1 |
| 186 | atropinics | 1 |
| 187 | audit | 1,437 |
| 188 | baff-871c | 3 |
| 189 | bakhtiari | 1 |
| 190 | barley-β-d-glucan | 1 |
| 191 | behar | 1 |
| 192 | behavior-matched | 1 |
| 193 | belgians | 4 |
| 194 | benefit-only | 2 |
| 195 | blown | 12 |
| 196 | bmimnsa | 4 |
| 197 | br/ | 3 |
| 198 | brain/behaviour | 1 |
| 199 | c.*+118a | 1 |
| 200 | c.*1025t | 2 |
| 201 | c.*1794c | 3 |
| 202 | c.*1961c | 1 |
| 203 | c.*2041t | 2 |
| 204 | c.*22c | 3 |
| 205 | c.*231a | 3 |
| 206 | c.*636a | 6 |
| 207 | c.*77c | 3 |
| 208 | c.-1088c | 1 |
| 209 | c.-460 | 1 |
| 210 | c.-64t | 2 |
| 211 | c.1003c | 2 |
| 212 | c.1081c | 2 |
| 213 | c.1133a | 1 |
| 214 | c.1150c | 2 |
| 215 | c.1158c | 2 |
| 216 | c.1171g | 1 |
| 217 | c.118-307g | 5 |
| 218 | c.118-308c | 3 |
| 219 | c.118c | 2 |
| 220 | c.1195c | 1 |
| 221 | c.1222c | 1 |
| 222 | c.1252t | 1 |
| 223 | c.1305c | 1 |
| 224 | c.1330g | 1 |
| 225 | c.1393-1g | 1 |
| 226 | c.1400c | 1 |
| 227 | c.1456c | 1 |
| 228 | c.1477c | 2 |
| 229 | c.1720c | 1 |
| 230 | c.175g | 1 |
| 231 | c.1799t | 2 |
| 232 | c.181t | 2 |
| 233 | c.1844c | 2 |
| 234 | c.1863+94a | 1 |
| 235 | c.1915g | 1 |
| 236 | c.1a | 5 |
| 237 | c.224g | 1 |
| 238 | c.234+1g | 1 |
| 239 | c.241c | 3 |
| 240 | c.2430t | 1 |
| 241 | c.259t | 1 |
| 242 | c.2633+1g | 2 |
| 243 | c.266c | 3 |
| 244 | c.26c | 2 |
| 245 | c.2929c | 1 |
| 246 | c.301c | 1 |
| 247 | c.3038a | 1 |
| 248 | c.3076c | 2 |
| 249 | c.31g | 2 |
| 250 | c.327g | 1 |
| 251 | c.345-2a | 1 |
| 252 | c.377a | 1 |
| 253 | c.378c | 1 |
| 254 | c.37a | 1 |
| 255 | c.388a | 3 |
| 256 | c.388c | 1 |
| 257 | c.396c | 1 |
| 258 | c.397t | 2 |
| 259 | c.4005-1g | 1 |
| 260 | c.406t | 1 |
| 261 | c.4213c | 1 |
| 262 | c.421c | 5 |
| 263 | c.422a | 1 |
| 264 | c.445c | 2 |
| 265 | c.4486t | 1 |
| 266 | c.4519c | 1 |
| 267 | c.459+1g | 1 |
| 268 | c.463c | 4 |
| 269 | c.482g | 1 |
| 270 | c.4956g | 1 |
| 271 | c.4975c | 1 |
| 272 | c.4987-3c | 1 |
| 273 | c.4g | 1 |
| 274 | c.5002t | 1 |
| 275 | c.506g | 1 |
| 276 | c.506t | 1 |
| 277 | c.5152+5g | 1 |
| 278 | c.516g | 3 |
| 279 | c.5219+1g | 1 |
| 280 | c.521t | 5 |
| 281 | c.539c | 1 |
| 282 | c.556-2a | 3 |
| 283 | c.578t | 1 |
| 284 | c.592c | 1 |
| 285 | c.597c | 1 |
| 286 | c.618g | 2 |
| 287 | c.629c | 1 |
| 288 | c.631g | 1 |
| 289 | c.639+5g | 1 |
| 290 | c.653c | 1 |
| 291 | c.674c | 1 |
| 292 | c.6884g | 1 |
| 293 | c.692c | 1 |
| 294 | c.712g | 1 |
| 295 | c.722a | 1 |
| 296 | c.726+54c | 2 |
| 297 | c.729+18c | 1 |
| 298 | c.7480c | 1 |
| 299 | c.74c | 1 |
| 300 | c.76c | 2 |
| 301 | c.784-1g | 1 |
| 302 | c.785a | 1 |
| 303 | c.78g | 1 |
| 304 | c.797g | 1 |
| 305 | c.79g | 2 |
| 306 | c.8175g | 1 |
| 307 | c.837-1g | 1 |
| 308 | c.844c | 1 |
| 309 | c.866g | 2 |
| 310 | c.8754+3g | 1 |
| 311 | c.886-3c | 1 |
| 312 | c.90c | 1 |
| 313 | c.913+1g | 1 |
| 314 | c.92+1g | 1 |
| 315 | c.92+6t | 1 |
| 316 | c.926a | 1 |
| 317 | c.93-21g | 1 |
| 318 | c.933+3a | 6 |
| 319 | c.935g | 2 |
| 320 | c.9610c | 1 |
| 321 | c.97c | 1 |
| 322 | campesterol≈β-sitosterol≥stigmasterol | 1 |
| 323 | cat-262c | 2 |
| 324 | catc.66+78c | 2 |
| 325 | ccmm | 3 |
| 326 | ce/tio2-20sio2-3.5al2o3 | 3 |
| 327 | cfef-ism | 5 |
| 328 | cfoa | 4 |
| 329 | chr17:40693129a | 1 |
| 330 | cin-lesions | 1 |
| 331 | colleague-to-colleague | 1 |
| 332 | computer-triggered | 2 |
| 333 | consensus-recommended | 1 |
| 334 | cornea/sclera | 1 |
| 335 | countermarketing | 3 |
| 336 | cqrm | 2 |
| 337 | crrc | 13 |
| 338 | ctri/2011/10/002094 | 1 |
| 339 | cv/ccc | 1 |
| 340 | cyp2d6≫cyp3a4 | 1 |
| 341 | decurarisation | 1 |
| 342 | des-ciclesonide | 1 |
| 343 | disadvantageously | 1 |
| 344 | doi:10.1002/sim.3113 | 1 |
| 345 | dot | 405 |
| 346 | dot-joining | 1 |
| 347 | dqtend | 1 |
| 348 | dream | 104 |
| 349 | dsofa | 3 |
| 350 | dvpi | 9 |
| 351 | e-e | 10 |
| 352 | e/e' | 4 |
| 353 | e713k | 1 |
| 354 | ebmeds | 1 |
| 355 | ecg/cg | 1 |
| 356 | eclipse | 70 |
| 357 | eds. | 1 |
| 358 | eeg/eps | 1 |
| 359 | egfr-216g | 1 |
| 360 | electrochemiluminescence-molecular | 3 |
| 361 | electroco- | 1 |
| 362 | encymatic | 1 |
| 363 | endopolygalacturonase | 1 |
| 364 | epiq | 7 |
| 365 | ethylene-bis-dytiokarbamates | 2 |
| 366 | ex15+572t | 1 |
| 367 | ex3-104c | 1 |
| 368 | ex4-76c | 2 |
| 369 | ex5+123c | 1 |
| 370 | excel | 143 |
| 371 | expert/professional | 1 |
| 372 | false-alarm-prone | 2 |
| 373 | fluorescence-dequenching | 1 |
| 374 | g.-158c | 2 |
| 375 | g.11187g | 2 |
| 376 | g.13863c | 1 |
| 377 | g.2603t | 1 |
| 378 | g.4338t | 1 |
| 379 | g.5082c | 1 |
| 380 | g.6986a | 1 |
| 381 | g.7920c | 1 |
| 382 | gapp | 2 |
| 383 | gem05 | 1 |
| 384 | gigadb | 2 |
| 385 | gucca | 1 |
| 386 | gwv | 5 |
| 387 | h2silibr | 1 |
| 388 | hc3.2 | 3 |
| 389 | hcahps | 10 |
| 390 | headline | 4 |
| 391 | heart-age | 5 |
| 392 | hnr | 15 |
| 393 | horna | 1 |
| 394 | hpmk | 3 |
| 395 | hr98pp | 1 |
| 396 | hspa1b-179c | 3 |
| 397 | hspa1b1267a | 1 |
| 398 | hygiene/barrier | 1 |
| 399 | iavc | 3 |
| 400 | ibfat | 3 |
| 401 | icpr | 31 |
| 402 | iief/domain | 2 |
| 403 | inclusive | 398 |
| 404 | information-specific | 1 |
| 405 | infrared-dried | 2 |
| 406 | inpact | 4 |
| 407 | intein-mediated | 1 |
| 408 | ipcrg | 5 |
| 409 | ipdas | 15 |
| 410 | iqcode-sf | 1 |
| 411 | iron-blood | 1 |
| 412 | isorhaponticin | 1 |
| 413 | ivs1-181c | 1 |
| 414 | ivs10+1g | 1 |
| 415 | ivs14+1g | 6 |
| 416 | ivs16-2a | 2 |
| 417 | ivs3-1g | 1 |
| 418 | ivs4+1g | 1 |
| 419 | ivs4+919g | 1 |
| 420 | ivs5+3a | 1 |
| 421 | ivs5-1g | 3 |
| 422 | ivs6-1g | 1 |
| 423 | ivs7+1g | 1 |
| 424 | ivs7-2a | 2 |
| 425 | ivsh-9c | 2 |
| 426 | jeeves | 1 |
| 427 | kg® | 1 |
| 428 | lcdsg | 7 |
| 429 | ldlr+patients | 1 |
| 430 | lecithotrophy | 1 |
| 431 | length-itpka | 1 |
| 432 | lif-csf | 3 |
| 433 | lipogram | 2 |
| 434 | loss-frame | 14 |
| 435 | luncheon | 11 |
| 436 | m.14484t | 1 |
| 437 | m.1555a | 4 |
| 438 | m.3243a | 4 |
| 439 | m.3460g | 1 |
| 440 | m.8344a | 1 |
| 441 | m.8344g | 1 |
| 442 | m11778g | 1 |
| 443 | m6/m6'-o-sulphate | 1 |
| 444 | macron | 25 |
| 445 | mania≥hypomania≥mixed-states≥psychosis | 1 |
| 446 | maude | 4 |
| 447 | max-i | 4 |
| 448 | mcph1-2550-c | 2 |
| 449 | median+ficolin-2 | 1 |
| 450 | men/ | 2 |
| 451 | metal-jacketed | 2 |
| 452 | methlamino | 1 |
| 453 | mir-149c | 3 |
| 454 | mir-499a | 5 |
| 455 | mmol/mmoverline | 1 |
| 456 | mrvenc | 3 |
| 457 | ms/dd-ms | 1 |
| 458 | mtr-2756a | 1 |
| 459 | much/a | 1 |
| 460 | nampt-948g | 1 |
| 461 | nct00152204 | 1 |
| 462 | nct01204502 | 2 |
| 463 | nct01586780 | 2 |
| 464 | nct01691053 | 1 |
| 465 | neutrally-framed | 1 |
| 466 | neutrino | 18 |
| 467 | nimh-genetics | 1 |
| 468 | non-deliverable | 1 |
| 469 | non-education | 4 |
| 470 | not-remembered | 1 |
| 471 | nrmp | 1 |
| 472 | o34 | 2 |
| 473 | oatp1c1-intron3c | 2 |
| 474 | octn1-917c | 3 |
| 475 | oldenburger | 1 |
| 476 | or/hr | 3 |
| 477 | or=-1.95 | 1 |
| 478 | or=-2.0 | 1 |
| 479 | or=30-day | 1 |
| 480 | ostradiol | 1 |
| 481 | page | 169 |
| 482 | pager | 3 |
| 483 | partner/family | 1 |
| 484 | password=cunningham | 1 |
| 485 | pathology-correlate | 2 |
| 486 | pc25 | 1 |
| 487 | pidd5 | 3 |
| 488 | placebo-condition | 1 |
| 489 | placebo-tailored | 2 |
| 490 | point-of-decision | 4 |
| 491 | popart | 11 |
| 492 | positively-framed | 2 |
| 493 | postcon-60s | 3 |
| 494 | pre-vignette | 1 |
| 495 | prime-sponsored | 1 |
| 496 | print-format | 1 |
| 497 | prism | 182 |
| 498 | problems» | 2 |
| 499 | prompt-type | 2 |
| 500 | protein-hsp104 | 1 |
| 501 | psunc | 6 |
| 502 | psvmean | 1 |
| 503 | pygs | 6 |
| 504 | qbtest | 4 |
| 505 | ramadan-focused | 2 |
| 506 | razavi | 1 |
| 507 | rentrop-grade | 1 |
| 508 | reposting | 1 |
| 509 | risk-only | 2 |
| 510 | rrm1-37c | 2 |
| 511 | rs13702t | 2 |
| 512 | rs2448490g | 2 |
| 513 | rs35599367c | 3 |
| 514 | rs3741379g | 2 |
| 515 | rs3814058c | 2 |
| 516 | rs5883-c | 1 |
| 517 | rs931127a | 2 |
| 518 | rs9930761-t | 1 |
| 519 | rules-based | 2 |
| 520 | rv5/rv6 | 1 |
| 521 | self-uncertain | 1 |
| 522 | serca-2 | 3 |
| 523 | several-folds | 1 |
| 524 | sfsc | 4 |
| 525 | sidebar | 3 |
| 526 | sky | 32 |
| 527 | slickgone | 1 |
| 528 | sms/text | 1 |
| 529 | solvent-water | 1 |
| 530 | sphero-cylindrical | 2 |
| 531 | sql | 4 |
| 532 | statpac | 1 |
| 533 | studies.key | 1 |
| 534 | sub | 401 |
| 535 | sup | 154 |
| 536 | symol | 1 |
| 537 | system-defined | 1 |
| 538 | tctt | 2 |
| 539 | testes-ni | 1 |
| 540 | text | 2,344 |
| 541 | text-articles | 1 |
| 542 | text/graphical | 1 |
| 543 | text/voice | 1 |
| 544 | the+3a | 1 |
| 545 | threat-framed | 1 |
| 546 | tm1camb | 1 |
| 547 | tm1fcr | 1 |
| 548 | tnf-308g | 2 |
| 549 | topbp1-3257-a | 2 |
| 550 | town:2004 | 1 |
| 551 | trans-2-nonenal | 4 |
| 552 | trap | 417 |
| 553 | tritri | 1 |
| 554 | tuh | 1 |
| 555 | tus-gfp | 2 |
| 556 | ungrammatical | 5 |
| 557 | unpleasent | 1 |
| 558 | unspoken | 1 |
| 559 | use-the | 1 |
| 560 | v158m | 1 |
| 561 | value-framed | 1 |
| 562 | waterhammer | 1 |
| 563 | weaker-risk | 1 |
| 564 | worse/low | 1 |
| 565 | www.cochranelibrary | 1 |
| 566 | www.crash.lshtm.ac.uk | 2 |
| 567 | yeaple | 37 |
| 568 | znbr | 1 |
| 569 | β-score | 5 |
| 570 | βoh | 4 |
| 571 | γ-cd | 4 |
| 572 | γ-glutamil-transpeptidase | 1 |
| 573 | ≤/ | 2 |
| 1 | e/e' | 4 |
| 2 | electroco- | 1 |
| 3 | 1.05. | 1 |
| 4 | eds. | 1 |
| 5 | =130/ | 2 |
| 6 | =/ | 5 |
| 7 | men/ | 2 |
| 8 | br/ | 3 |
| 9 | ≤/ | 2 |
| 10 | or=-2.0 | 1 |
| 11 | 10.0/12.0 | 1 |
| 12 | 5.0/7.0 | 1 |
| 13 | 1/1,000 | 3 |
| 14 | 70/100 | 6 |
| 15 | 347,500 | 1 |
| 16 | acr-pedi30 | 2 |
| 17 | 0-0.40 | 1 |
| 18 | c.-460 | 1 |
| 19 | 420-780 | 1 |
| 20 | nct01586780 | 2 |
| 21 | 5α-reductase-1 | 2 |
| 22 | 2010-18776-001 | 1 |
| 23 | 2011-19419-001 | 1 |
| 24 | 2015-15269-001 | 1 |
| 25 | 56,451 | 1 |
| 26 | 1.45-5.61 | 1 |
| 27 | /=-2 | 1 |
| 28 | serca-2 | 3 |
| 29 | median+ficolin-2 | 1 |
| 30 | hc3.2 | 3 |
| 31 | 0.20-1.02 | 1 |
| 32 | 2011-19228-002 | 4 |
| 33 | nct01204502 | 2 |
| 34 | 2col2 | 1 |
| 35 | 34:1885-1903 | 1 |
| 36 | doi:10.1002/sim.3113 | 1 |
| 37 | nct01691053 | 1 |
| 38 | 31:1249-1263 | 1 |
| 39 | ab3 | 7 |
| 40 | ce/tio2-20sio2-3.5al2o3 | 3 |
| 41 | 491.4 | 1 |
| 42 | town:2004 | 1 |
| 43 | protein-hsp104 | 1 |
| 44 | nct00152204 | 1 |
| 45 | o34 | 2 |
| 46 | 465,754 | 1 |
| 47 | ctri/2011/10/002094 | 1 |
| 48 | cyp2d6≫cyp3a4 | 1 |
| 49 | -1.1-0.5 | 1 |
| 50 | 22-32.5 | 1 |
| 51 | 2004-15935-005 | 2 |
| 52 | gem05 | 1 |
| 53 | 0.25-1.15 | 2 |
| 54 | pc25 | 1 |
| 55 | 29,385 | 1 |
| 56 | or=-1.95 | 1 |
| 57 | pidd5 | 3 |
| 58 | arg136 | 3 |
| 59 | rv5/rv6 | 1 |
| 60 | 3.3-4.7 | 2 |
| 61 | 2008-07317-008 | 1 |
| 62 | 15:325-328 | 1 |
| 63 | 127,458 | 1 |
| 64 | 0.07-0.59 | 3 |
| 65 | 34:588-599 | 1 |
| 66 | == | 1 |
| 67 | topbp1-3257-a | 2 |
| 68 | much/a | 1 |
| 69 | +5650a | 3 |
| 70 | c.1a | 5 |
| 71 | c.*231a | 3 |
| 72 | 61a | 2 |
| 73 | 531-2a | 1 |
| 74 | 3244-2a | 1 |
| 75 | c.345-2a | 1 |
| 76 | ivs16-2a | 2 |
| 77 | c.556-2a | 3 |
| 78 | ivs7-2a | 2 |
| 79 | c.422a | 1 |
| 80 | c.722a | 1 |
| 81 | c.933+3a | 6 |
| 82 | ivs5+3a | 1 |
| 83 | the+3a | 1 |
| 84 | c.1133a | 1 |
| 85 | m.3243a | 4 |
| 86 | -204a | 3 |
| 87 | m.8344a | 1 |
| 88 | -1984a | 3 |
| 89 | c.1863+94a | 1 |
| 90 | m.1555a | 4 |
| 91 | 175a | 2 |
| 92 | c.785a | 1 |
| 93 | 406a | 2 |
| 94 | c.926a | 1 |
| 95 | c.*636a | 6 |
| 96 | 2846a | 3 |
| 97 | mtr-2756a | 1 |
| 98 | 66a | 1 |
| 99 | 1166a | 3 |
| 100 | 6986a | 4 |
| 101 | g.6986a | 1 |
| 102 | rs931127a | 2 |
| 103 | c.37a | 1 |
| 104 | 1267a | 2 |
| 105 | hspa1b1267a | 1 |
| 106 | 48867a | 1 |
| 107 | 277a | 1 |
| 108 | c.377a | 1 |
| 109 | 118a | 6 |
| 110 | c.*+118a | 1 |
| 111 | c.3038a | 1 |
| 112 | 2168a | 3 |
| 113 | 388a | 1 |
| 114 | c.388a | 3 |
| 115 | 1298a | 2 |
| 116 | chr17:40693129a | 1 |
| 117 | mir-499a | 5 |
| 118 | gucca | 1 |
| 119 | 10kda | 4 |
| 120 | dsofa | 3 |
| 121 | length-itpka | 1 |
| 122 | /formula | 7 |
| 123 | horna | 1 |
| 124 | cfoa | 4 |
| 125 | 4-cqa | 1 |
| 126 | cornea/sclera | 1 |
| 127 | bmimnsa | 4 |
| 128 | gigadb | 2 |
| 129 | tm1camb | 1 |
| 130 | sub | 401 |
| 131 | /sub | 153 |
| 132 | mcph1-2550-c | 2 |
| 133 | rs5883-c | 1 |
| 134 | c.1400c | 1 |
| 135 | c.9610c | 1 |
| 136 | c.1720c | 1 |
| 137 | g.7920c | 1 |
| 138 | 3050c | 1 |
| 139 | c.1150c | 2 |
| 140 | c.7480c | 1 |
| 141 | c.90c | 1 |
| 142 | c.301c | 1 |
| 143 | 421c | 8 |
| 144 | c.421c | 5 |
| 145 | c.241c | 3 |
| 146 | 1451c | 4 |
| 147 | c.*1961c | 1 |
| 148 | baff-871c | 3 |
| 149 | c.1081c | 2 |
| 150 | ivs1-181c | 1 |
| 151 | 191c | 1 |
| 152 | c.*22c | 3 |
| 153 | c.1222c | 1 |
| 154 | 8622c | 1 |
| 155 | cat-262c | 2 |
| 156 | g.5082c | 1 |
| 157 | 2382c | 2 |
| 158 | c.592c | 1 |
| 159 | c.692c | 1 |
| 160 | c.886-3c | 1 |
| 161 | c.4987-3c | 1 |
| 162 | c.1003c | 2 |
| 163 | c.4213c | 1 |
| 164 | ex5+123c | 1 |
| 165 | c.653c | 1 |
| 166 | 3953c | 1 |
| 167 | 263c | 2 |
| 168 | c.463c | 4 |
| 169 | g.13863c | 1 |
| 170 | oatp1c1-intron3c | 2 |
| 171 | ex3-104c | 1 |
| 172 | -514c | 1 |
| 173 | 34c | 7 |
| 174 | 744c | 4 |
| 175 | c.844c | 1 |
| 176 | c.1844c | 2 |
| 177 | c.726+54c | 2 |
| 178 | c.74c | 1 |
| 179 | c.674c | 1 |
| 180 | c.*1794c | 3 |
| 181 | c.1305c | 1 |
| 182 | 3435c | 15 |
| 183 | c.445c | 2 |
| 184 | c.4975c | 1 |
| 185 | c.1195c | 1 |
| 186 | -1306c | 2 |
| 187 | c.26c | 2 |
| 188 | 1236c | 2 |
| 189 | 936c | 3 |
| 190 | c.1456c | 1 |
| 191 | 2166c | 2 |
| 192 | c.266c | 3 |
| 193 | ex4-76c | 2 |
| 194 | c.76c | 2 |
| 195 | c.3076c | 2 |
| 196 | 1976c | 3 |
| 197 | -3186c | 2 |
| 198 | c.396c | 1 |
| 199 | 1896c | 2 |
| 200 | octn1-917c | 3 |
| 201 | rrm1-37c | 2 |
| 202 | rs35599367c | 3 |
| 203 | c.*77c | 3 |
| 204 | c.1477c | 2 |
| 205 | 677c | 24 |
| 206 | c.97c | 1 |
| 207 | c.597c | 1 |
| 208 | c.118-308c | 3 |
| 209 | c.729+18c | 1 |
| 210 | c.118c | 2 |
| 211 | rs3814058c | 2 |
| 212 | g.-158c | 2 |
| 213 | c.1158c | 2 |
| 214 | catc.66+78c | 2 |
| 215 | c.378c | 1 |
| 216 | c.-1088c | 1 |
| 217 | c.388c | 1 |
| 218 | 1298c | 1 |
| 219 | ivsh-9c | 2 |
| 220 | c.4519c | 1 |
| 221 | -629c | 4 |
| 222 | c.629c | 1 |
| 223 | c.2929c | 1 |
| 224 | c.539c | 1 |
| 225 | mir-149c | 3 |
| 226 | 1459c | 2 |
| 227 | +69c | 1 |
| 228 | hspa1b-179c | 3 |
| 229 | statpac | 1 |
| 230 | cv/ccc | 1 |
| 231 | information-specific | 1 |
| 232 | 25-topic | 1 |
| 233 | encymatic | 1 |
| 234 | mrvenc | 3 |
| 235 | psunc | 6 |
| 236 | crrc | 13 |
| 237 | sfsc | 4 |
| 238 | iavc | 3 |
| 239 | 0.10g/d | 1 |
| 240 | 12g/d | 2 |
| 241 | γ-cd | 4 |
| 242 | consensus-recommended | 1 |
| 243 | behavior-matched | 1 |
| 244 | infrared-dried | 2 |
| 245 | value-framed | 1 |
| 246 | anger-framed | 2 |
| 247 | threat-framed | 1 |
| 248 | positively-framed | 2 |
| 249 | neutrally-framed | 1 |
| 250 | system-defined | 1 |
| 251 | 1compared | 1 |
| 252 | not-remembered | 1 |
| 253 | computer-triggered | 2 |
| 254 | placebo-tailored | 2 |
| 255 | prime-sponsored | 1 |
| 256 | rules-based | 2 |
| 257 | ramadan-focused | 2 |
| 258 | intein-mediated | 1 |
| 259 | metal-jacketed | 2 |
| 260 | .0001-and | 1 |
| 261 | dqtend | 1 |
| 262 | iron-blood | 1 |
| 263 | e-e | 10 |
| 264 | text/voice | 1 |
| 265 | rentrop-grade | 1 |
| 266 | anti-insecticide | 1 |
| 267 | des-ciclesonide | 1 |
| 268 | maude | 4 |
| 269 | heart-age | 5 |
| 270 | page | 169 |
| 271 | use-the | 1 |
| 272 | non-deliverable | 1 |
| 273 | yeaple | 37 |
| 274 | loss-frame | 14 |
| 275 | alme | 1 |
| 276 | headline | 4 |
| 277 | mmol/mmoverline | 1 |
| 278 | adenine/guanine | 1 |
| 279 | slickgone | 1 |
| 280 | false-alarm-prone | 2 |
| 281 | prompt-type | 2 |
| 282 | β-score | 5 |
| 283 | γ-glutamil-transpeptidase | 1 |
| 284 | acetylcholinestrease | 1 |
| 285 | endopolygalacturonase | 1 |
| 286 | eclipse | 70 |
| 287 | m6/m6'-o-sulphate | 1 |
| 288 | pathology-correlate | 2 |
| 289 | pre-vignette | 1 |
| 290 | colleague-to-colleague | 1 |
| 291 | 0.05.twenty-five | 1 |
| 292 | inclusive | 398 |
| 293 | /inf | 3 |
| 294 | iqcode-sf | 1 |
| 295 | lif-csf | 3 |
| 296 | -900g | 3 |
| 297 | c.1330g | 1 |
| 298 | -50g | 1 |
| 299 | -250g | 2 |
| 300 | =1750g | 1 |
| 301 | m.3460g | 1 |
| 302 | rs2448490g | 2 |
| 303 | 590g | 2 |
| 304 | ivs10+1g | 1 |
| 305 | c.92+1g | 1 |
| 306 | c.913+1g | 1 |
| 307 | c.2633+1g | 2 |
| 308 | ivs14+1g | 6 |
| 309 | c.234+1g | 1 |
| 310 | ivs4+1g | 1 |
| 311 | ivs7+1g | 1 |
| 312 | c.5219+1g | 1 |
| 313 | c.459+1g | 1 |
| 314 | c.1393-1g | 1 |
| 315 | ivs3-1g | 1 |
| 316 | c.784-1g | 1 |
| 317 | c.4005-1g | 1 |
| 318 | ivs5-1g | 3 |
| 319 | ivs6-1g | 1 |
| 320 | c.837-1g | 1 |
| 321 | c.93-21g | 1 |
| 322 | c.31g | 2 |
| 323 | 5331g | 2 |
| 324 | c.631g | 1 |
| 325 | c.1171g | 1 |
| 326 | 18281g | 1 |
| 327 | 681g | 3 |
| 328 | c.712g | 1 |
| 329 | -842g | 1 |
| 330 | 472g | 2 |
| 331 | -572g | 3 |
| 332 | c.482g | 1 |
| 333 | 1192g | 4 |
| 334 | c.8754+3g | 1 |
| 335 | c.4g | 1 |
| 336 | +5714g | 3 |
| 337 | c.224g | 1 |
| 338 | m.8344g | 1 |
| 339 | -174g | 5 |
| 340 | c.6884g | 1 |
| 341 | 894g | 4 |
| 342 | akt1-snp4g | 1 |
| 343 | c.5152+5g | 1 |
| 344 | c.639+5g | 1 |
| 345 | +405g | 2 |
| 346 | c.1915g | 1 |
| 347 | 1725g | 4 |
| 348 | c.935g | 2 |
| 349 | c.175g | 1 |
| 350 | c.8175g | 1 |
| 351 | c.506g | 1 |
| 352 | egfr-216g | 1 |
| 353 | c.516g | 3 |
| 354 | 1236g | 1 |
| 355 | c.4956g | 1 |
| 356 | c.866g | 2 |
| 357 | c.118-307g | 5 |
| 358 | c.327g | 1 |
| 359 | 857g | 1 |
| 360 | 957g | 4 |
| 361 | 2677g | 6 |
| 362 | g.11187g | 2 |
| 363 | -287g | 2 |
| 364 | c.797g | 1 |
| 365 | tnf-308g | 2 |
| 366 | c.618g | 2 |
| 367 | nampt-948g | 1 |
| 368 | -458g | 2 |
| 369 | c.78g | 1 |
| 370 | +378g | 2 |
| 371 | 2678g | 1 |
| 372 | m11778g | 1 |
| 373 | ivs4+919g | 1 |
| 374 | -1639g | 5 |
| 375 | c.79g | 2 |
| 376 | rs3741379g | 2 |
| 377 | 211ag | 1 |
| 378 | ecg/cg | 1 |
| 379 | 140mmhg | 8 |
| 380 | /=80mmhg | 4 |
| 381 | 90mmhg | 6 |
| 382 | 40kg | 3 |
| 383 | fluorescence-dequenching | 1 |
| 384 | dot-joining | 1 |
| 385 | 'conflicting | 1 |
| 386 | countermarketing | 3 |
| 387 | abstinence-promoting | 1 |
| 388 | reposting | 1 |
| 389 | /strong | 1 |
| 390 | ipcrg | 5 |
| 391 | lcdsg | 7 |
| 392 | acefhigh | 1 |
| 393 | βoh | 4 |
| 394 | tuh | 1 |
| 395 | adhd-rs-i | 3 |
| 396 | max-i | 4 |
| 397 | /i | 25 |
| 398 | amthi | 2 |
| 399 | testes-ni | 1 |
| 400 | dvpi | 9 |
| 401 | bakhtiari | 1 |
| 402 | tritri | 1 |
| 403 | razavi | 1 |
| 404 | e713k | 1 |
| 405 | hpmk | 3 |
| 406 | weaker-risk | 1 |
| 407 | www.crash.lshtm.ac.uk | 2 |
| 408 | 2.5mmol/l | 5 |
| 409 | text/graphical | 1 |
| 410 | sphero-cylindrical | 2 |
| 411 | ungrammatical | 5 |
| 412 | trans-2-nonenal | 4 |
| 413 | expert/professional | 1 |
| 414 | acceptance/refusal | 3 |
| 415 | 6.0mg/dl | 3 |
| 416 | excel | 143 |
| 417 | 3ng/ml | 2 |
| 418 | 4000pg/ml | 1 |
| 419 | ostradiol | 1 |
| 420 | 3mg/mmol | 1 |
| 421 | symol | 1 |
| 422 | campesterol≈β-sitosterol≥stigmasterol | 1 |
| 423 | 0.01/control | 2 |
| 424 | sql | 4 |
| 425 | -terphenyl | 1 |
| 426 | -2-methylpropyl | 2 |
| 427 | 500cells/μl | 1 |
| 428 | v158m | 1 |
| 429 | dream | 104 |
| 430 | 'steam | 1 |
| 431 | password=cunningham | 1 |
| 432 | lipogram | 2 |
| 433 | /em | 7 |
| 434 | 5/100mm | 1 |
| 435 | ccmm | 3 |
| 436 | 0.4mom | 1 |
| 437 | 0.27microm | 1 |
| 438 | cqrm | 2 |
| 439 | cfef-ism | 5 |
| 440 | prism | 182 |
| 441 | barley-β-d-glucan | 1 |
| 442 | psvmean | 1 |
| 443 | unspoken | 1 |
| 444 | iief/domain | 2 |
| 445 | self-uncertain | 1 |
| 446 | isorhaponticin | 1 |
| 447 | luncheon | 11 |
| 448 | point-of-decision | 4 |
| 449 | atropine-premedication | 1 |
| 450 | non-education | 4 |
| 451 | decurarisation | 1 |
| 452 | placebo-condition | 1 |
| 453 | macron | 25 |
| 454 | blown | 12 |
| 455 | methlamino | 1 |
| 456 | neutrino | 18 |
| 457 | trap | 417 |
| 458 | tus-gfp | 2 |
| 459 | nrmp | 1 |
| 460 | hr98pp | 1 |
| 461 | gapp | 2 |
| 462 | sup | 154 |
| 463 | /sup | 99 |
| 464 | epiq | 7 |
| 465 | sidebar | 3 |
| 466 | behar | 1 |
| 467 | electrochemiluminescence-molecular | 3 |
| 468 | h2silibr | 1 |
| 469 | znbr | 1 |
| 470 | tm1fcr | 1 |
| 471 | pager | 3 |
| 472 | oldenburger | 1 |
| 473 | hygiene/barrier | 1 |
| 474 | waterhammer | 1 |
| 475 | solvent-water | 1 |
| 476 | 200/microliter | 2 |
| 477 | or/hr | 3 |
| 478 | hnr | 15 |
| 479 | icpr | 31 |
| 480 | brain/behaviour | 1 |
| 481 | postcon-60s | 3 |
| 482 | ipdas | 15 |
| 483 | atlas | 182 |
| 484 | atropinics | 1 |
| 485 | nimh-genetics | 1 |
| 486 | ebmeds | 1 |
| 487 | several-folds | 1 |
| 488 | text-articles | 1 |
| 489 | anilinopirymidynes | 2 |
| 490 | ethylene-bis-dytiokarbamates | 2 |
| 491 | jeeves | 1 |
| 492 | pygs | 6 |
| 493 | mania≥hypomania≥mixed-states≥psychosis | 1 |
| 494 | astlevels | 1 |
| 495 | 40-ms | 3 |
| 496 | ms/dd-ms | 1 |
| 497 | belgians | 4 |
| 498 | cin-lesions | 1 |
| 499 | eeg/eps | 1 |
| 500 | hcahps | 10 |
| 501 | 60yrs | 2 |
| 502 | ldlr+patients | 1 |
| 503 | acknowledgements | 1 |
| 504 | acknowledgments | 3 |
| 505 | adpβs | 1 |
| 506 | rs9930761-t | 1 |
| 507 | 2430t | 2 |
| 508 | c.2430t | 1 |
| 509 | 521t | 5 |
| 510 | c.521t | 5 |
| 511 | -1131t | 1 |
| 512 | c.*2041t | 2 |
| 513 | 341t | 2 |
| 514 | c.181t | 2 |
| 515 | c.5002t | 1 |
| 516 | rs13702t | 2 |
| 517 | 142t | 3 |
| 518 | c.1252t | 1 |
| 519 | ex15+572t | 1 |
| 520 | +3003t | 1 |
| 521 | g.2603t | 1 |
| 522 | 11193t | 1 |
| 523 | -604t | 3 |
| 524 | -524t | 1 |
| 525 | c.-64t | 2 |
| 526 | m.14484t | 1 |
| 527 | 1025t | 2 |
| 528 | c.*1025t | 2 |
| 529 | 335t | 1 |
| 530 | +45t | 2 |
| 531 | c.92+6t | 1 |
| 532 | c.406t | 1 |
| 533 | c.506t | 1 |
| 534 | c.4486t | 1 |
| 535 | -786t | 6 |
| 536 | c.397t | 2 |
| 537 | g.4338t | 1 |
| 538 | c.578t | 1 |
| 539 | -429t | 1 |
| 540 | c.259t | 1 |
| 541 | c.1799t | 2 |
| 542 | ibfat | 3 |
| 543 | print-format | 1 |
| 544 | inpact | 4 |
| 545 | apft | 15 |
| 546 | audit | 1,437 |
| 547 | amrit | 3 |
| 548 | unpleasent | 1 |
| 549 | dot | 405 |
| 550 | popart | 11 |
| 551 | /st | 8 |
| 552 | qbtest | 4 |
| 553 | tctt | 2 |
| 554 | text | 2,344 |
| 555 | sms/text | 1 |
| 556 | gwv | 5 |
| 557 | worse/low | 1 |
| 558 | ar-c69931mx | 2 |
| 559 | or=30-day | 1 |
| 560 | studies.key | 1 |
| 561 | lecithotrophy | 1 |
| 562 | sky | 32 |
| 563 | partner/family | 1 |
| 564 | risk-only | 2 |
| 565 | benefit-only | 2 |
| 566 | disadvantageously | 1 |
| 567 | www.cochranelibrary | 1 |
| 568 | amorphicity | 1 |
| 569 | apology/responsibility | 1 |
| 570 | 3□ | 3 |
| 571 | 4□ | 1 |
| 572 | kg® | 1 |
| 573 | problems» | 2 |